Patents by Inventor Robert K. Winn

Robert K. Winn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of inhibiting cell death or inflammation in a mammal by administering a BCL protein
    Patent number: 8304389
    Abstract: In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: November 6, 2012
    Assignee: University of Washington through its Center for Commercialization, a Public Institution of Higher Education
    Inventors: John M. Harlan, Robert K. Winn, Akiko Iwata, Joan Tupper, John Li
  • METHODS OF INHIBITING CELL DEATH OR INFLAMMATION IN A MAMMAL BY ADMINISTERING A BCL PROTEIN
    Publication number: 20110312901
    Abstract: In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
    Type: Application
    Filed: May 13, 2011
    Publication date: December 22, 2011
    Inventors: John M. Harlan, Robert K. Winn, Akiko Iwata, Joan Tupper, John Li
  • Methods of Inhibiting Cell Death or Inflammation in a Mammal
    Publication number: 20110263510
    Abstract: Methods are provided for inhibiting cell death or inflammation in a mammal concurrent with or after the onset of a condition expected to lead to cell death or inflammation. The methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. Methods are also provided for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal concurrent with or after the onset of a condition expected to lead to cell death or inflammation.
    Type: Application
    Filed: November 8, 2007
    Publication date: October 27, 2011
    Inventors: John M. Harlan, Robert K. Winn
  • Method of inhibiting inflammation in a mammal by administering Bcl protein
    Patent number: 7964565
    Abstract: In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
    Type: Grant
    Filed: October 4, 2005
    Date of Patent: June 21, 2011
    Assignee: University of Washington Center for Commercialization, a Public Institution of Higher Education
    Inventors: John M. Harlan, Robert K. Winn, Akiko Iwata, Joan Tupper, John Li
  • Methods of Inhibiting Cell Death or Inflammation in a Mammal
    Publication number: 20110082072
    Abstract: In one aspect the present invention provides methods for inhibiting cell death or inflammation in a mammal, wherein the methods each include the step of administering to a mammal a Bcl protein in an amount sufficient to inhibit cell death or inflammation in the mammal. The invention also provides methods for identifying a Bcl protein that inhibits cell death or inflammation when administered to a mammal.
    Type: Application
    Filed: October 4, 2005
    Publication date: April 7, 2011
    Applicant: University of Washington
    Inventors: John M. Harlan, Robert K. Winn, Akiko Iwata, Joan Tupper, John Li
  • METHODS FOR TREATING OR PREVENTING HEART FAILURE
    Publication number: 20110021433
    Abstract: The invention provides methods for inhibiting cell death or inflammation in a mammal brought about by diseases or conditions such as heart failure, wherein the method comprises administering to a mammal in need thereof a Bcl protein in an amount sufficient to inhibit cell death and inflammation in the mammal.
    Type: Application
    Filed: February 1, 2010
    Publication date: January 27, 2011
    Inventors: John M. Harlan, Robert K. Winn, Akiko Iwata
  • THERAPY OR PREVENTION OF DISEASES WITH CELLS OR CELL SUPERNATANT
    Publication number: 20100297094
    Abstract: Methods and compositions for the treatment or prevention of diseases or disorders including media conditioned by mesenchymal stem cells and BCL2A1 are provided. Methods for the production of therapeutic or preventative compositions contacted with BCL2A1 are also provided.
    Type: Application
    Filed: February 1, 2010
    Publication date: November 25, 2010
    Inventors: John M. Harlan, Robert K. Winn
  • METHODS AND COMPOSITIONS FOR INHIBITING INFLAMMATION ASSOCIATED WITH PULMONARY DISEASE
    Publication number: 20010006656
    Abstract: The present invention provides an aerosol formulation of a 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor. The HMG-CoA reductase inhibitor can be, for example, a statin such as lovastatin, pravastatin, simvastatin, cerivastatin, fluvastatin, atorvastatin or mevastatin. The invention also provides a method of treating a pulmonary disease with an aerosol formulation of a HMG-CoA reductase inhibitor.
    Type: Application
    Filed: February 17, 1999
    Publication date: July 5, 2001
    Applicant: UNIVERSITY OF WASHINGTON
    Inventors: JOHN M. HARLAN, ROBERT K. WINN, LI LIU